SCHEMBL7656365

SCHEMBL7656365

Nc1nc(Cl)nc2c1ncn2[C@@H]1CC[C@@H](O)C1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 7/20 0.60
ADORA2A P29274 2/20 0.60
ADORA1 P30542 2/20 0.60
PNP P00491 1/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
HTT P42858 1/20 0.55
PDE4D Q08499 1/20 0.55
PDE3A Q14432 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
RXFP1 Q9HBX9 1/20 0.55
CHKA P35790 8/20 0.53
HSP90AA1 P07900 2/20 0.51
HSP90B1 P14625 2/20 0.51
TMEM97 Q5BJF2 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
CHKB Q9Y259 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7665371 0.99 ADORA3 (0.59) ADORA3ADORA2AADORA1PNPLMNA
Hydrochloric Acid SCHEMBL9075807 0.85 AHCY (0.54) ADORA3ADORA2AADORA1HSP90B1
Hydrochloric Acid SCHEMBL7846299 0.85 AHCY (0.54) ADORA3ADORA2AADORA1HSP90B1
SCHEMBL19503306 0.84 PDE4D (0.57) ADORA3ADORA2AADORA1PNPLMNA
SCHEMBL19503483 0.84 PDE4D (0.57) ADORA3ADORA2AADORA1PNPLMNA
SCHEMBL19820789 0.82 CHKA (0.56) ADORA3ADORA2AADORA1CHKACHKB
SCHEMBL19820625 0.82 CHKA (0.56) ADORA3ADORA2AADORA1CHKACHKB
SCHEMBL9021496 0.82 NT5E (0.43) ADORA3ADORA2AADORA1CHKA
SCHEMBL9021493 0.82 NT5E (0.43) ADORA3ADORA2AADORA1CHKA
SCHEMBL9021704 0.82 NT5E (0.43) ADORA3ADORA2AADORA1CHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436947-B1 TO PREVENT ALLOGRAFT REJECTION; AUTOIMMUNE DISEASES DUE TO ACTION OF T-CELLS AS INSULIN-DEPENDENT DIABETES, MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS; SUPPRESSION OF HUMORAL IMMUNE RESPONSE IN TREATMENT OF MYESTHENIAGRAVIS, LUPUS ERYTHEMATOSUS AVENTIS PHARMACEUTICALS INC. 2002-08-20 US claimed